Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 6/20 | 0.73 |
| ▸ | PTPN7 | P35236 | 5/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.54 |
| ▸ | RECQL | P46063 | 2/20 | 0.54 |
| ▸ | SELP | P16109 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.51 |
| ▸ | BLM | P54132 | 1/20 | 0.51 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
| ▸ | PPARG | P37231 | 4/20 | 0.50 |
| ▸ | PPARD | Q03181 | 4/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tridecanoate SCHEMBL4901631 | 0.87 | GPR84 (0.65) | TDP1RECQLALDH1A1MEN1KMT2A | |
| Tetraethylene Glycol SCHEMBL689010 | 0.87 | GPR84 (0.65) | TDP1RECQLALDH1A1MEN1KMT2A | |
| Tetraethylene Glycol SCHEMBL7997286 | 0.87 | GPR84 (0.65) | TDP1RECQLALDH1A1MEN1KMT2A | |
| Triethylene Glycol SCHEMBL3322022 | 0.87 | GPR84 (0.65) | TDP1RECQLALDH1A1MEN1KMT2A | |
| Pentaethylene Glycol SCHEMBL9014237 | 0.87 | GPR84 (0.65) | TDP1RECQLALDH1A1MEN1KMT2A | |
| Octanoic Acid SCHEMBL23631740 | 0.87 | GPR84 (0.65) | TDP1RECQLALDH1A1MEN1KMT2A | |
| Octanoic Acid SCHEMBL11237647 | 0.87 | GPR84 (0.65) | TDP1RECQLALDH1A1MEN1KMT2A | |
| Hexaethylene Glycol SCHEMBL5145927 | 0.87 | GPR84 (0.65) | TDP1RECQLALDH1A1MEN1KMT2A | |
| Nonanoate SCHEMBL3124773 | 0.87 | GPR84 (0.65) | TDP1RECQLALDH1A1MEN1KMT2A | |
| Stearic Acid SCHEMBL1993427 | 0.87 | GPR84 (0.65) | TDP1RECQLALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070014731-A1 | Contrast agents | GE HEALTHCARE | 2007-01-18 | — | — | US | disclosed |
| US-20040131548-A1 | Contrast agents | AMERSHAM HEALTH AS | 2004-07-08 | — | — | US | disclosed |
| EP-0576519-B1 | IMPROVEMENTS IN OR RELATING TO CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 2001-04-18 | — | — | EP | disclosed |
| US-6106806-A | DIAGNOTIC ULTRASOUND; BIODEGRADABLE | NYCOMED IMAGING AS (NO) | 2000-08-22 | — | — | US | disclosed |
| US-5567413-A | CONTRAST AGENT COMPRISING VESICLES OG PHOSPHOLIPID MATERIAL | NYCOMED IMAGING AS (NO) | 1996-10-22 | — | — | US | disclosed |
| US-5536490-A | ULTRASOUND OF VASCULAR SYSTEMS | NYCOMED IMAGING AS (NO) | 1996-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070014731-A1 | Contrast agents | FABP3, ANXA4, ANXA5 | HMGCR 3454/4885PTPN7 3368/4885TDP1 4344/4885 |
| US-20040131548-A1 | Contrast agents | FABP3, ANXA4, ANXA5 | HMGCR 3454/4885PTPN7 3368/4885TDP1 4344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.